Table 1.
Clinical features of the patients’ cohort.
Case | Age/ gender |
Race/ ethnicity |
Reconstruction | Primary disease | Time to disease (years) |
Specimen type |
Stage | Treatment | Follow- up (months) |
Outcome |
---|---|---|---|---|---|---|---|---|---|---|
1 | 60/M | NA | Ileal conduit | Bladder exstrophy | 40 | Resection | pT4N1 | Surgery | 7 | AWOD |
2 | 53/F | White | Ileal conduit | Vesicoureteral reflux | 48 | Resection | pT1Nx | Surgery | 48 | AWOD |
3 | 58/F | White | Ileal conduit | Urothelial carcinoma | 2 | Resection | T3Nx | Chemotherapy Radiation | 82 | AWOD |
4 | 59/M | White | Ileal conduit | Bladder exstrophy | 58 | Resection | pT2N2b | Surgery | 7 | DOU |
5 | 38/M | White | Ileal conduit | Obstructive uropathy s/p kidney transplant | 36 | Resection | pT2N2 | Surgery Chemotherapy | 9.5 | LTF |
6 | 36/M | White | Gastrocystoplasty | Reflux nephropathy s/p kidney transplant | 24 | Resection | pT3aN2 | Surgery Chemotherapy | 8.5 | DOD |
7 | 29/M | White | Gastrocystoplasty | Renal dysplasia | 26 | TURBT | pT2N3M1 | Surgery Chemotherapy | 18 | AWD |
8 | 50/F | White | Colo-cystoplasty converted to ileal conduit | End-stage bladder s/p chemotherapy | 44 | Biopsy | pT1NxM1 | Radiation Immunotherapy | 7 | AWD |
9 | 59/M | White | Ileal conduit | Diabetes insipidus and bladder dysfunction | Childhood | Biopsy | NA | Chemotherapy | 2 | AWD |
10 | 70/M | White | Indiana pouch | Leiomyosarcoma bladder | 6 | Resection | pT2N1a | Surgery Chemotherapy | 24 | LTF |
11 | 57/M | NA | Augmentation cystoplasty | NA | Childhood | Resection | pT1Nx | Surgery | 63 | AWOD |
Abbreviations: NA, not available; AWOD, alive without disease; AWD, alive with disease; DOU, died of unknown cause; DOD, died of disease; LTF, lost to follow-up.